Related Experiment Video
Updated: Jan 10, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Exploring differences in HIV stigma and treatment interruptions between young and older adults in Zimbabwe
Venessa Chen1, Gnilane Turpin2, Omar Syarif3
1Johns Hopkins Bloomberg School of Public Health, Baltimore, United States. vchen28@jh.edu.
Introduction:
HIV stigma negatively impacts antiretroviral therapy (ART) adherence in adults, but this relationship remains underexplored within the context of early adulthood. We examined manifestations of stigma and their associations with ART interruptions among young (18-24 years) and older (25 + years) people living with HIV (PLHIV) in Zimbabwe.
Methods:
This analysis utilized cross-sectional data from the 2021 PLHIV Stigma Index 2.0, implemented by the Zimbabwe National Network of PLHIV in partnership with Global Network of People Living with HIV, The International Community of Women Living with HIV, and UNAIDS. Treatment interruptions were defined as ever interrupting or stopping HIV treatment. Internalized, anticipated, and enacted stigma scores were categorized as "no", "low", "moderate" and "high". Modified Poisson regression models estimated associations between categorized stigma scores and treatment interruptions, with age-stratified analyses among young and older adults.
Results:
Among 1347 PLHIV who ever initiated ART, 20.9% of young adults and 10.3% of older adults reported treatment interruptions. Experiences of internalized stigma (56.3% versus 41.7%, p < 0.01) and anticipated stigma (73.9% versus 51.8%, p < 0.01) were higher among young adults compared to older adults. Increasing levels of internalized stigma were associated with higher lifetime incidence of treatment interruptions compared to no stigma (low: adjusted risk ratio(aRR)1.67, 95%CI 1.08-2.58, moderate: aRR2.58, 95%CI 1.72-3.87, high: aRR3.54, 95%CI 2.11-5.94). Similar associations were observed with anticipated stigma (low: aRR2.24, 95%CI 1.49-3.36, moderate: aRR3.21, 95%CI 1.82-5.66, high: aRR4.88, 95%CI 2.75-8.67). Treatment interruptions were associated with high (versus no) enacted stigma (aRR 2.75, 95%CI 1.19-6.32).
Conclusion:
Young adults living with HIV in Zimbabwe reported twice the lifetime incidence of treatment interruptions and greater levels of internalized and anticipated stigma compared to older adults. The associations between stigma and treatment interruptions highlight the opportunity for interventions that address stigma for young adults, which may optimize treatment adherence during early adulthood.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Stereotypes, Prejudice, and Discrimination
Ethics in Research
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

